Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00153517 · ClinicalTrials.gov registry record · Phase 2
Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy
A Phase 2 study of Premature Birth and Birth Weight, sponsored by Centers for Disease Control and Prevention.
- Completed
- Registry status
- Phase 2
- Development phase
- 126
- Enrollment target
- 1
- Study location
NCT00153517: Completed Phase 2 study of Premature Birth and Birth Weight, sponsored by Centers for Disease Control and Prevention.
NCT00153517 is a Phase 2 study of Premature Birth and Birth Weight that has completed, run by Centers for Disease Control and Prevention. The registered enrollment target is 126 participants, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00153517, a Phase 2 study of Premature Birth and Birth Weight, has completed, sponsored by Centers for Disease Control and Prevention.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 126 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and intravaginal metronidazole for the treatment of BV 3. To study the efficacy of oral and intravaginal metronidazole for the prevention of hospital admission during the 3rd trimester, chorioamnionitis, preterm delivery, and maternal infectious morbidity.
Primary Outcome
Cure rates were assessed by Gram Stain Score (0-3, 4-6, 7-10); Abnormal clincial signs (0, 1-2, 3-4); Therapeutic cure (Gram Stain 0-3 and no symptoms) treatment
Conditions Studied
Interventions
- DRUG oral versus vaginal metronidazole
Study Locations (1)
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 1999-10 |
| Est. Completion | 2004-09 |
| Phase | Phase 2 |
What the finished NCT00153517 record still lists
NCT00153517 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 391-participant average among 38 other Premature Birth trials with a reported enrollment target (68% lower).
The record links to 4 conditions, with Premature Birth appearing as the primary indexed condition, and to 1 intervention - of which oral versus vaginal metronidazole is the first listed.
NCT00153517 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT00153517 about?
NCT00153517 is a clinical study titled "Maternal Effects of Bacterial Vaginosis (BV) Treatment in Pregnancy". The goal of this study is to examine acceptability and efficacy of 2 kinds of BV treatment among women at low risk for preterm delivery. The objectives are: 1. To examine the side effects and patient acceptability of oral versus intravaginal metronidazole. 2. To compare the efficacy of oral and int...
What is the current status of trial NCT00153517?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 126 participants. The study started on 1999-10. Estimated completion is 2004-09.
What conditions does trial NCT00153517 study?
This clinical trial studies the following conditions: Premature Birth, Birth Weight, Chorioamnionitis, Vaginosis, Bacterial.
What interventions are being tested in trial NCT00153517?
The interventions under investigation include: oral versus vaginal metronidazole (DRUG).
Who is sponsoring clinical trial NCT00153517?
This trial is sponsored by Centers for Disease Control and Prevention, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00153517 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00153517's enrollment target sits among peer trials
126 17th of 38 higher than 22 of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Trial Comparing Misoprostol and Foley Bulb for Labor Induction in the Preterm Gestation
COMPLETED · Phase 2
-
Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age
RECRUITING · Phase 4
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia